The global polyclonal antibodies market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The growing use of polyclonal antibodies in various research applications primarily drive market growth. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen and thus are highly utilized in general research applications. Adding to this, the globally rising incidence of cancer led by the significant rise in awareness campaigns and research funding on cancer is expected to boost their further use in the disease treatment. For instance, in 2018, the UK Government funded around $300 million for cancer treatment.

Besides cancer, the growing global incidence of infectious diseases including the Ebola virus, particularly in under-developed countries, is anticipated to drive the market growth during the forecast period. For instance, as per the World Health Organization (WHO) in February 2020, the outbreak of the Ebola virus in West Africa was the largest outbreak during 2014-2016 and it still continues in various countries.

Some key players operating in the market include Agilent Technologies, Inc., Abcam plc, Thermo Fisher Scientific Inc, and Merck KGaA, among others. The market players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, investment in research and development, and so on. For instance, in August 2018, SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, announced that its anti-Ebola immunotherapy, SAB-139, offers100% protection against a lethal dose of the Ebola virus in an animal study published in The Journal of Infectious Diseases. The study was conducted by the National Interagency Confederation for Biological Research in collaboration with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC).

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Agilent Technologies, Inc., Abcam plc, Thermo Fisher Scientific Inc, and Merck KGaA, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Polyclonal Antibodies Market by Segment

By Type 

• Primary Antibody 

• Secondary Antibody

By Application 

• Academic Research 

• Commercial Application

Global Polyclonal Antibodies Market by Region